This HTML5 document contains 116 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n9http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q54317902
rdf:type
wikibase:Item
schema:description
naučni članak article científic artykuł naukowy 2014年學術文章 artículo científico publicado en 2014 ২ অক্টোবর ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico научна статия 2014年学术文章 επιστημονικό άρθρο 2014年学术文章 2014 nî lūn-bûn vetenskaplig artikel 2014년 논문 2014年學術文章 bài báo khoa học wetenschappelijk artikel artigo científico scientific article published on 2 October 2014 2014 թվականի հոկտեմբերի 2-ին հրատարակված գիտական հոդված 2014年学术文章 2014年学术文章 artículu científicu мақолаи илмӣ vedecký článok bilimsel makale artikel ilmiah articolo scientifico 2014年學術文章 artikulong pang-agham vitenskapelig artikkel teaduslik artikkel מאמר מדעי 2014年學術文章 wissenschaftlicher Artikel наукова стаття, опублікована в жовтні 2014 tudományos cikk tieteellinen artikkeli artigo científico scienca artikolo scientific article published on 2 October 2014 научни чланак научная статья scientific article published on 2 October 2014 2014年学术文章 2014年の論文 vitskapeleg artikkel บทความทางวิทยาศาสตร์ სამეცნიერო სტატია 2014年学术文章 مقالة علمية نشرت في 2 أكتوبر 2014 vědecký článek 2014年學術文章 artikull shkencor videnskabelig artikel article scientific articol științific article scientifique научни чланак
p:P577
wds:Q54317902-B972B359-E596-492D-BED4-4E1A35FFC34D
wdt:P577
2014-10-02T00:00:00Z
p:P407
wds:Q54317902-46D32132-A6A9-477B-9035-10B413CCE1FC
wdt:P407
wd:Q1860
p:P2860
wds:Q54317902-0020378E-1E35-4B51-9D3F-9B9D8E461A59
wdt:P2860
wd:Q27851406
p:P2093
wds:Q54317902-B8CAE585-480E-4E95-ACA6-9B9DE4A63EBE wds:Q54317902-8EABC6FB-76DC-4B9D-9253-D55F8B54A34E wds:Q54317902-90CC26F0-B454-48B3-BFC5-71B2A2280945 wds:Q54317902-426B7014-9FDF-482A-886B-05EB2DE14BC1 wds:Q54317902-2901FD5A-F9CA-4453-BE4D-C9ACDFB4A0FA wds:Q54317902-FB7F8F4A-7F5C-4157-8980-4F90E87CEA3E wds:Q54317902-F08C2BC1-6D0C-4EE4-AB0A-5A18A810F5EF wds:Q54317902-CF8212C4-899C-431C-96B3-2C0AD386473C wds:Q54317902-D643DFEF-C239-40A0-8F30-E959C92F9C8E
wdt:P2093
Karen Wood Begoña de Las Heras Khin Than Myint L Rhoda Molife Montserrat Blanco-Codesido Galina Kuznetsov Lucy Lee Andre T Brunetto Malcolm Richard Ranson
rdfs:label
A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors. A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors.
skos:prefLabel
A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors. A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors.
schema:name
A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors. A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors.
p:P50
wds:Q54317902-2C79BAC9-C835-4008-8EF4-A4FAAA6BF88D wds:Q54317902-AAA04E32-1FE1-46E6-AE20-BDB2ADC9909E wds:Q54317902-6E88EAE8-EA87-4F5C-A66A-3B7AA093B504 wds:Q54317902-CCF66D63-75AB-4948-B002-53BCE08337B8
wdt:P50
wd:Q41438258 wd:Q37828894 wd:Q54317984 wd:Q54317995
p:P1476
wds:Q54317902-7F893CB7-10C8-434F-B7AA-02761C8EE43A
wdt:P1476
A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors.
p:P304
wds:Q54317902-F89CB453-61F0-47E3-8856-C44A8B23A89F
wdt:P304
6284-6294
p:P31
wds:Q54317902-F3CBDAC8-3263-4B2D-905C-D5F3D3649249
wdt:P31
wd:Q13442814
p:P698
wds:Q54317902-2000F158-ADBE-40FD-8B1C-C0548316998A
wdtn:P698
n12:25278451
wdt:P698
25278451
p:P1433
wds:Q54317902-F062DFC8-4FD7-48B3-B9E4-3553BD0B5321
wdt:P1433
wd:Q332253
p:P433
wds:Q54317902-E9174D94-1ABB-4713-9706-25EC8DE22F0A
p:P478
wds:Q54317902-A138DC97-548F-4497-81F1-7995FD2DE48C
wdt:P433
24
wdt:P478
20
p:P356
wds:Q54317902-B86307B2-80EE-4799-B52E-F07D1EAD815A
wdtn:P356
n9:1078-0432.CCR-14-0409
wdt:P356
10.1158/1078-0432.CCR-14-0409